Page last updated: 2024-09-03

ro 43-5054 and thromboxane b2

ro 43-5054 has been researched along with thromboxane b2 in 1 studies

Compound Research Comparison

Studies (ro 43-5054)	Trials (ro 43-5054)	Recent Studies (post-2010) (ro 43-5054)	Studies (thromboxane b2)	Trials (thromboxane b2)	Recent Studies (post-2010) (thromboxane b2)
9	0	0	7,483	715	485

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fitzgerald, DJ; Murphy, NP; Pratico, D	1

Other Studies

1 other study(ies) available for ro 43-5054 and thromboxane b2

Article	Year
Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:2 Topics: Acetates; Animals; Binding Sites; Blood Platelets; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Hemorrhage; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thromboxane B2; Tissue Plasminogen Activator; Tyrosine	1998

Article

Year

Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.

The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:2

Topics: Acetates; Animals; Binding Sites; Blood Platelets; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Hemorrhage; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thromboxane B2; Tissue Plasminogen Activator; Tyrosine

1998